(Q36702078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Leah Leibovitch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Gideon Paret

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

57-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17209664%20AND%20SRC:MED&resulttype=core&format=json

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767010-00005

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767010-00005

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767010-00005

Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767010-00005

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

12 December 2020

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

12 December 2020

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

12 December 2020

Sildenafil for pulmonary hypertension after heart transplantation

1 reference

12 December 2020

Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy

1 reference

12 December 2020

A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.

1 reference

12 December 2020

Current treatment strategies for pulmonary arterial hypertension

1 reference

12 December 2020

Infant pertussis deaths and the management of cardiovascular compromise.

1 reference

12 December 2020

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension

1 reference

12 December 2020

Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors

1 reference

12 December 2020

Idiopathic pulmonary arterial hypertension in children.

1 reference

12 December 2020

Pulmonary hypertension in the newborn

1 reference

12 December 2020

Effects of long-term bosentan in children with pulmonary arterial hypertension.

1 reference

12 December 2020

Chronic oral sildenafil therapy in severe pulmonary artery hypertension.

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Chronic outpatient sildenafil therapy for pulmonary hypertension in a child after cardiac surgery

1 reference

12 December 2020

Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension

1 reference

12 December 2020

Oral sildenafil for treatment of severe pulmonary hypertension in an infant

1 reference

12 December 2020

Sildenafil in the management of idiopathic pulmonary arterial hypertension in children and adolescents

1 reference

12 December 2020

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

1 reference

12 December 2020

Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil

1 reference

12 December 2020

Drug treatment of pulmonary arterial hypertension: current and future agents

1 reference

12 December 2020

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

1 reference

12 December 2020

Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension in children

1 reference

12 December 2020

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

1 reference

12 December 2020

Nitric oxide in the pathogenesis of sepsis

1 reference

12 December 2020

Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

1 reference

12 December 2020

Diagnosis and treatment of severe pediatric pulmonary hypertension

1 reference

12 December 2020

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases

1 reference

12 December 2020

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

1 reference

12 December 2020

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

1 reference

12 December 2020

One hundred years of research in the pathogenesis of pulmonary hypertension

1 reference

12 December 2020

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study

1 reference

12 December 2020

No evidence for severe retinopathy of prematurity following sildenafil

1 reference

12 December 2020

Congenital heart disease in relation to pulmonary hypertension in paediatric practice

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with oral sildenafil

1 reference

12 December 2020

Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study

1 reference

12 December 2020

Primary pulmonary hypertension in childhood

1 reference

12 December 2020

Sildenafil for primary and secondary pulmonary hypertension

1 reference

12 December 2020

Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension

1 reference

12 December 2020

Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury

1 reference

12 December 2020

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

1 reference

12 December 2020

Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease

1 reference

12 December 2020

Sildenafil as a treatment for pulmonary hypertension

1 reference

12 December 2020

Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome

1 reference

12 December 2020

Pulmonary arterial hypertension in children

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

1 reference

12 December 2020

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

1 reference

12 December 2020

Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device

1 reference

12 December 2020

Clinical classification of pulmonary hypertension.

1 reference

12 December 2020

Detrimental effects of verapamil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Sildenafil: emerging cardiovascular indications

1 reference

12 December 2020

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

1 reference

12 December 2020

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

1 reference

12 December 2020